Trademarks

ALLTRANZ

Serial number
85599967
Registration number
4564661
Filed
2012-04-17
Registered
2014-07-08
Status
Registration cancelled 2021-02-12 (USPTO status code 710, 2021-02-12; as of the dataset)
Classes
001, 005, 042
Elsewhere
USPTO TSDR record (current status) ↗
Source
TRCFECO2, file of 2024-03-27

Goods and services

Chemicals for use in the manufacture of pharmaceuticals | Pharmaceutical preparations, both prescription and over-the-counter, for human and animal use, namely, analgesics, anti-inflammatories, antiarthritic preparations, preparations for treating nausea and vertigo, preparations for the relief of pain and skin irritations, pharmaceutical preparations for enhancing topical penetration of drug delivery through the skin and mucous membranes; tranquilizers and psychotropics; medicated skin care preparations, namely, medicated skin creams, gels, antibiotic ointments and lotions for human and animal use; cleansing solutions for medical use, transdermal patches for use in the treatment of alcoholism, Alzheimer's disease, anorexia, anxiety disorders, appetite modulation, arthritis, cachexia, depression, drug addiction, inflammation, multiple sclerosis, neuralgia, neuropathic pain, obesity, opiate dependence, osteo-arthritis, pain, postsurgical pain, postherpetic neuralgia, seizure disorders, sleep disorders, and cerebrovascular disease; pharmaceutical preparations for the treatment of pain, substance addiction, substance abuse, muscle spasms, treatment of alcoholism, and treatment of neurodegeneration; veterinary products, namely, topical medicated treatments, namely, ointments, creams, solutions, gels, patches, poultices, and plasters for use in the relief of inflammation, arthritis, muscle spasms, pain, dermatitis and skin irritations; veterinary products, namely, pharmaceutical preparations for treating nausea and vertigo, cleansing solutions for medical use, transdermal patches for use in the treatment of anxiety disorders, appetite modulation, cachexia, depression, neuralgia, neuropathic pain, obesity, postsurgical pain, seizure disorders, sleep disorders, and cerebrovascular disease; veterinary dermal and transdermal devices, namely, microneedles sold filled with medication for the treatment of anxiety disorders, appetite modulation, cachexia, depression, neuralgia, neuropathic pain, obesity, postsurgical pain, seizure disorders, sleep disorders, and cerebrovascular disease, and for use in the relief of inflammation, arthritis, muscle spasms, pain, osteoarthritis pain, dermatitis and skin inflammation | Pharmaceutical research and development services

Owners

OwnerRoleEntityPlaceAlso on furp.orgSource
Alltranz Inc.Original applicant, Owner at publication, Original registrantCorporationLexington, KYTRCFECO2, file of 2024-03-27
ZYNERBA PHARMACEUTICALS, INC.New owner after registrationCorporationDEVON, PAZYNERBA PHARMACEUTICALS, INC. Federal lobbying client EXACT high confidence: identical full name and stateTRCFECO2, file of 2024-03-27

Assignment history

RecordedWhatFromToReel/frameSource
2017-11-20Name change
Change of name
ALLTRANZ INC.ZYNERBA PHARMACEUTICALS, INC. DEVON, PA6209/162TRASECO, file of 2026-09-29

USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.